Please use this identifier to cite or link to this item: https://repositorio.ufrn.br/jspui/handle/123456789/19023
Title: Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson’s Disease: New Perspectives to a Long-Standing Model
Authors: Leão, Anderson H.F.F.
Sarmento-Silva, Aldair J.
Santos, José R.
Ribeiro, Alessandra M.
Silva, Regina H.
Keywords: animal model;dopamine;Parkinson’s disease;reserpine;rodent
Issue Date: 2-Mar-2015
Publisher: International Society of Neuropathology
Citation: LEÃO, Anderson H.F.F. et al. Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson’s Disease: New Perspectives to a Long-Standing Model. Brain Pathology. doi:10.1111/bpa.12253
Abstract: he administration of reserpine to rodents was one of the first models used to investigate the pathophysiology and screening for potential treatments of Parkinson’s disease (PD). The reserpine model was critical to the understanding of the role of monoamine system in the regulation of motor and affective disorders, as well as the efficacy of current PD treatments, such as L-DOPA and dopamine agonists. Nevertheless, with the introduction of toxin-induced and genetic models of PD, reserpine became underused. The main rationale to this drawback was the supposed absence of reserpine construct validity with PD. Here, we highlight classical and recent experimental findings that support the face, pharmacological, and construct validity of reserpine PD model and reason against the current rationale for its underuse. We also aim to shed a new perspective upon the model by discussing the main challenges and potentials for the reserpine model of PD.
URI: https://repositorio.ufrn.br/jspui/handle/123456789/19023
ISSN: 1015-6305
Appears in Collections:ICe - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
AndersonLeao_ICE_Molecular_Neurochemical_2015.pdfArtigo completo341.63 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.